BioWorld MedTech

July 26, 2016

Tso3's Sterizone seen as revolutionary weapon in the treatment of superbugs, other bacteria

Canada's Tso3 Inc. has won expanded FDA clearance for its Sterizone VP4 sterilizer making it the only company validated to completely sterilize large, complex and hard-to-clean medical instruments, said company CEO Ric Rumble. Read More

Co-development of companion diagnostics raises unanswered guidance questions

Zimmer's India push aims to meet growing orthopedic needs

Aiming for turnaround,Zosano presses ahead in pivotal migraine trial

Technology 'focused' on destroying prostate cancer gaining traction in U.S.

Other news to note

Product briefs

Financings

Appointments and advancements

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 31, 2026.

Illustration of dopamine signaling in the brain

New schizophrenia targets challenge trial design

BioWorld

The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...

AIDS 2026: New targets for metabolic dysfunction despite ART

BioWorld

Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 28, 2026

Jingxin discloses new muscarinic and sigma receptor agonists

BioWorld Science

Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...